About
Technology
Issues
FAQ
Links
Official Page
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.